These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


107 related items for PubMed ID: 32172002

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Serum cross-linked N-telopeptide of type I collagen across the canine life span: An investigation in intact and neutered male and female dogs.
    Yamaguchi F, Nishi H, Misumi K, Fujiki M.
    Res Vet Sci; 2021 May; 136():609-615. PubMed ID: 33901785
    [Abstract] [Full Text] [Related]

  • 3. Effects of electroacupuncture on bone mass and cathepsin K expression in ovariectomised rats.
    Zhou J, Li X, Liao Y, Feng W, Guo X.
    Acupunct Med; 2014 Dec; 32(6):478-85. PubMed ID: 25193930
    [Abstract] [Full Text] [Related]

  • 4. Osteoporotic risk and physeal closure in prepubertal ovariohysterectomized cats.
    Uçmak M, Yılmaz ÖT, Gündüz MC, Uçmak ZG, Duzgun O, Eskiyurt N, Oruç CU, Genç S, Erzengin ÖM, Karaçam E.
    Anim Reprod Sci; 2015 Oct; 161():146-51. PubMed ID: 26386680
    [Abstract] [Full Text] [Related]

  • 5. Multiparameter analysis of serum levels of C-telopeptide crosslaps, bone-specific alkaline phosphatase, cathepsin K, osteoprotegerin and receptor activator of nuclear factor κB ligand in the diagnosis of osteoporosis.
    Piatek S, Adolf D, Wex T, Halangk W, Klose S, Westphal S, Amthauer H, Winckler S.
    Maturitas; 2013 Apr; 74(4):363-8. PubMed ID: 23391500
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of modal damping factor as a diagnostic tool for osteoporosis and its relation with serum osteocalcin and collagen I N-telopeptide for monitoring the efficacy of alendronate in ovariectomized rats.
    Christopoulou GE, Stavropoulou A, Anastassopoulos G, Panteliou SD, Papadaki E, Karamanos NK, Panagiotopoulos E.
    J Pharm Biomed Anal; 2006 Jun 07; 41(3):891-7. PubMed ID: 16488571
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Excretion of urinary N-telopeptides reflects changes in bone turnover during ovarian suppression and indicates individually variable estradiol threshold for bone loss.
    Dmowski WP, Rana N, Pepping P, Cain DF, Clay TH.
    Fertil Steril; 1996 Dec 07; 66(6):929-36. PubMed ID: 8941057
    [Abstract] [Full Text] [Related]

  • 11. The effect of short-term treatment with micronized estradiol on bone turnover and gonadotrophins in older men.
    Taxel P, Kennedy D, Fall P, Willard A, Shoukri K, Clive J, Raisz LG.
    Endocr Res; 2000 Aug 07; 26(3):381-98. PubMed ID: 11019903
    [Abstract] [Full Text] [Related]

  • 12. Proteolysis of human bone collagen by cathepsin K: characterization of the cleavage sites generating by cross-linked N-telopeptide neoepitope.
    Atley LM, Mort JS, Lalumiere M, Eyre DR.
    Bone; 2000 Mar 07; 26(3):241-7. PubMed ID: 10709996
    [Abstract] [Full Text] [Related]

  • 13. Determination of bone markers in pycnodysostosis: effects of cathepsin K deficiency on bone matrix degradation.
    Nishi Y, Atley L, Eyre DE, Edelson JG, Superti-Furga A, Yasuda T, Desnick RJ, Gelb BD.
    J Bone Miner Res; 1999 Nov 07; 14(11):1902-8. PubMed ID: 10571690
    [Abstract] [Full Text] [Related]

  • 14. The effect of gonadotropin-releasing hormone agonist on type I collagen C-telopeptide and N-telopeptide: the predictive value of biochemical markers of bone turnover.
    Amama EA, Taga M, Minaguchi H.
    J Clin Endocrinol Metab; 1998 Feb 07; 83(2):333-8. PubMed ID: 9467536
    [Abstract] [Full Text] [Related]

  • 15. Cathepsin K predicts femoral neck bone mineral density change in nonosteoporotic peri- and early postmenopausal women.
    Prezelj J, Ostanek B, Logar DB, Marc J, Hawa G, Kocjan T.
    Menopause; 2008 Feb 07; 15(2):369-73. PubMed ID: 17882010
    [Abstract] [Full Text] [Related]

  • 16. Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study.
    Garnero P, Sornay-Rendu E, Claustrat B, Delmas PD.
    J Bone Miner Res; 2000 Aug 07; 15(8):1526-36. PubMed ID: 10934651
    [Abstract] [Full Text] [Related]

  • 17. An Increased Serum N-Terminal Telopeptide of Type I Collagen, a Biochemical Marker of Increased Bone Resorption, Is Associated with Infliximab Therapy in Patients with Crohn's Disease.
    Sugimoto K, Ikeya K, Iida T, Kawasaki S, Arai O, Umehara K, Watanabe F, Tani S, Oishi S, Osawa S, Yamamoto T, Hanai H.
    Dig Dis Sci; 2016 Jan 07; 61(1):99-106. PubMed ID: 26254083
    [Abstract] [Full Text] [Related]

  • 18. Effect of ovariohysterectomy at the time of tumor removal in dogs with benign mammary tumors and hyperplastic lesions: a randomized controlled clinical trial.
    Kristiansen VM, Nødtvedt A, Breen AM, Langeland M, Teige J, Goldschmidt M, Jonasdottir TJ, Grotmol T, Sørenmo K.
    J Vet Intern Med; 2013 Jan 07; 27(4):935-42. PubMed ID: 23701181
    [Abstract] [Full Text] [Related]

  • 19. Effects of combined ovariectomy with dexamethasone on rat lumbar vertebrae.
    Ren H, Liang D, Shen G, Yao Z, Jiang X, Tang J, Cui J, Lin S.
    Menopause; 2016 Apr 07; 23(4):441-50. PubMed ID: 26694734
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.